|Bid||0.00 x 3200|
|Ask||44.09 x 1300|
|Day's range||43.85 - 44.73|
|52-week range||32.83 - 51.86|
|Beta (5Y monthly)||0.68|
|PE ratio (TTM)||18.75|
|Earnings date||25 Oct 2021 - 29 Oct 2021|
|Forward dividend & yield||1.56 (3.53%)|
|Ex-dividend date||29 July 2021|
|1y target est||46.03|
23andMe Co-Founder & CEO Anne Wojcicki joins 'Influencers with Andy Serwer' to discuss the future of personal genomics.
Dr. Howard Forman, Yale Radiology and Public Health Professor joins Yahoo Finance’s Anjalee Khemlani and the Yahoo Finance Live panel with the latest COVD-19 vaccine update.
J&J vaccine data shows lasting durability and strong booster efficacy. However the company has yet to begin trials for a COVID-19 vaccine for children.